calendar
6,533 catalysts · 3,603 8k filing · 1,000 device adverse event · 773 grant · 578 earnings · 220 approval · 172 phase 2 completion
next 91 dayslessmore
MonWedFri
6,533 catalysts · 3,603 8k filing · 1,000 device adverse event · 773 grant · 578 earnings · 220 approval · 172 phase 2 completion
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 8.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 5.07, 9.01
Items: 2.02, 9.01
Items: 4.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 9.01